Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA safety study for fluorescence-guided brain tumor resection in children and adolescents
2014-005669-54Phase 2Active
- Sponsor
- Universität Münster
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in brain neoplasm, glioma, astrocytoma, ependymoma, Atypical teratoid rhabdoid tumor (ATRT), sponsored by Universität Münster. Started Dec 2019; status: active.
02
Drugs
5-aminolevulinic acid
03
Conditions
brain neoplasmgliomaastrocytomaependymomaAtypical teratoid rhabdoid tumor (ATRT)
Beyond the preview
Go deeper on 2014-005669-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005669-54.